| Margaret Dennin Bruns, MD | |
|
900 Cummings Ctr Ste 311t, Beverly, MA 01915-6260 | |
| (978) 225-3376 | |
| Not Available |
| Full Name | Margaret Dennin Bruns |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Location | 900 Cummings Ctr Ste 311t, Beverly, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356830731 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 290801 (Massachusetts) | Primary |
| Entity Name | Massachusetts Dermatology Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396167763 PECOS PAC ID: 4284864331 Enrollment ID: O20140311001042 |
News Archive
Neurotez, Inc. today announced the grant of U.S. Patent number 8,227,408 by the United States Patent and Trademark Office covering the company's lead product candidate, Leptin. The patent protects use of the hormone Leptin for treating a progressive cognitive disease, disorder or condition, such as Alzheimer's disease (AD), resulting from accumulation of an amyloid peptide or for improving resilience of cognitive function by modulating the accumulation of the amyloid peptide in brain.
In the early 1990s, drug production in Colombia diversified to include heroin as well as cocaine, and since then the country's role in the heroin trade has substantially increased. According to the United Nations Office on Drugs and Crime, Colombia produced approximately 70 to 100 metric tons of heroin between 1998 and 2004. Studies have found an increase in local heroin use since the mid-1990s. This is a strong cause for concern, given the potential for HIV to spread through networks of injection drug users and disseminate to the general public.
Scientific research has shed new light on dissociative symptoms and dissociative identity disorder, formerly known as multiple personality disorder. This condition seems to arise most often when a vulnerable person meets a therapist with a suggestive line of questioning or encounters sensationalized media portrayals of dissociation. Research shows that people with rich fantasy lives may be especially susceptible to such influences.
Research presented today by UT Southwestern cardiologists at the annual American Heart Association (AHA) Scientific Sessions 2020 showed that Black and Hispanic people were more likely to be hospitalized with COVID-19 than white patients, and that nonwhite men with cardiovascular disease or risk factors were more likely to die.
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, commented on the Draft Guidance for Industry on Minimal Manipulation of Human Cells, Tissues, and Cellular and Tissue-Based Products ("HCT/Ps") that the Food and Drug Administration ("FDA") published for comment on December 23, 2014.
› Verified 9 days ago
| Entity Name | Massderm Billing Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033655667 PECOS PAC ID: 2062837503 Enrollment ID: O20200731000650 |
News Archive
Neurotez, Inc. today announced the grant of U.S. Patent number 8,227,408 by the United States Patent and Trademark Office covering the company's lead product candidate, Leptin. The patent protects use of the hormone Leptin for treating a progressive cognitive disease, disorder or condition, such as Alzheimer's disease (AD), resulting from accumulation of an amyloid peptide or for improving resilience of cognitive function by modulating the accumulation of the amyloid peptide in brain.
In the early 1990s, drug production in Colombia diversified to include heroin as well as cocaine, and since then the country's role in the heroin trade has substantially increased. According to the United Nations Office on Drugs and Crime, Colombia produced approximately 70 to 100 metric tons of heroin between 1998 and 2004. Studies have found an increase in local heroin use since the mid-1990s. This is a strong cause for concern, given the potential for HIV to spread through networks of injection drug users and disseminate to the general public.
Scientific research has shed new light on dissociative symptoms and dissociative identity disorder, formerly known as multiple personality disorder. This condition seems to arise most often when a vulnerable person meets a therapist with a suggestive line of questioning or encounters sensationalized media portrayals of dissociation. Research shows that people with rich fantasy lives may be especially susceptible to such influences.
Research presented today by UT Southwestern cardiologists at the annual American Heart Association (AHA) Scientific Sessions 2020 showed that Black and Hispanic people were more likely to be hospitalized with COVID-19 than white patients, and that nonwhite men with cardiovascular disease or risk factors were more likely to die.
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, commented on the Draft Guidance for Industry on Minimal Manipulation of Human Cells, Tissues, and Cellular and Tissue-Based Products ("HCT/Ps") that the Food and Drug Administration ("FDA") published for comment on December 23, 2014.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Margaret Dennin Bruns, MD 900 Cummings Ctr Ste 311t, Beverly, MA 01915-6260 Ph: (978) 225-3376 | Margaret Dennin Bruns, MD 900 Cummings Ctr Ste 311t, Beverly, MA 01915-6260 Ph: (978) 225-3376 |
News Archive
Neurotez, Inc. today announced the grant of U.S. Patent number 8,227,408 by the United States Patent and Trademark Office covering the company's lead product candidate, Leptin. The patent protects use of the hormone Leptin for treating a progressive cognitive disease, disorder or condition, such as Alzheimer's disease (AD), resulting from accumulation of an amyloid peptide or for improving resilience of cognitive function by modulating the accumulation of the amyloid peptide in brain.
In the early 1990s, drug production in Colombia diversified to include heroin as well as cocaine, and since then the country's role in the heroin trade has substantially increased. According to the United Nations Office on Drugs and Crime, Colombia produced approximately 70 to 100 metric tons of heroin between 1998 and 2004. Studies have found an increase in local heroin use since the mid-1990s. This is a strong cause for concern, given the potential for HIV to spread through networks of injection drug users and disseminate to the general public.
Scientific research has shed new light on dissociative symptoms and dissociative identity disorder, formerly known as multiple personality disorder. This condition seems to arise most often when a vulnerable person meets a therapist with a suggestive line of questioning or encounters sensationalized media portrayals of dissociation. Research shows that people with rich fantasy lives may be especially susceptible to such influences.
Research presented today by UT Southwestern cardiologists at the annual American Heart Association (AHA) Scientific Sessions 2020 showed that Black and Hispanic people were more likely to be hospitalized with COVID-19 than white patients, and that nonwhite men with cardiovascular disease or risk factors were more likely to die.
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, commented on the Draft Guidance for Industry on Minimal Manipulation of Human Cells, Tissues, and Cellular and Tissue-Based Products ("HCT/Ps") that the Food and Drug Administration ("FDA") published for comment on December 23, 2014.
› Verified 9 days ago
Lilit Garibyan, M.D, PH.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 900 Cummings Ctr Ste 311t, Beverly, MA 01915 Phone: 978-225-3376 Fax: 978-560-1245 | |
Dr. David S Greenstein, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 138 Conant St, 1st Fl, Beverly, MA 01915 Phone: 978-927-5254 Fax: 978-927-5174 | |
Dr. Adriane Ann Levin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 900 Cummings Ctr Ste 311t, Beverly, MA 01915 Phone: 978-225-3376 | |
Sabina Bis, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 900 Cummings Ctr Ste 311t, Beverly, MA 01915 Phone: 978-225-3376 | |
Gary S Rogers, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 85 Herrick St, Oncology Center, Beverly, MA 01915 Phone: 978-524-7933 Fax: 978-524-7954 | |
Dr. Robb J Marchione, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 138 Conant St, 1st Floor, Beverly, MA 01915 Phone: 978-927-5254 Fax: 978-921-1418 |